UA115894C2 - Місцева антимікробна дерматологічна композиція - Google Patents

Місцева антимікробна дерматологічна композиція

Info

Publication number
UA115894C2
UA115894C2 UAA201508442A UAA201508442A UA115894C2 UA 115894 C2 UA115894 C2 UA 115894C2 UA A201508442 A UAA201508442 A UA A201508442A UA A201508442 A UAA201508442 A UA A201508442A UA 115894 C2 UA115894 C2 UA 115894C2
Authority
UA
Ukraine
Prior art keywords
dermatological composition
topical antimicrobial
composition
antimicrobial dermatological
topical
Prior art date
Application number
UAA201508442A
Other languages
English (en)
Inventor
Жан-Клод Аляр (померлий)
Жан-Марі Лефевр
Жак ПЕЙРО
Original Assignee
Лаборатуар Теа С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Теа С.А.С. filed Critical Лаборатуар Теа С.А.С.
Publication of UA115894C2 publication Critical patent/UA115894C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід стосується застосування місцевої антимікробної дерматологічної композиції у виробництві лікарського засобу офтальмологічного призначення, яка містить в комбінації щонайменше один катіонний антимікробний пептид, зв'язаний з ліпідом, та гіалуронову кислоту з молекулярною масою від 200 кДа до 600 кДа або її сіль, де антимікробний пептид є гексапептидом, зв'язаним з пальмітиновою кислотою, що містить дисульфідні містки, та де композиція знаходиться у формі для зовнішнього місцевого застосування.
UAA201508442A 2013-02-28 2014-02-24 Місцева антимікробна дерматологічна композиція UA115894C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1351766A FR3002452B1 (fr) 2013-02-28 2013-02-28 Composition dermatologique antimicrobienne topique
PCT/FR2014/050383 WO2014131974A1 (fr) 2013-02-28 2014-02-24 Composition dermatologique antimicrobienne topique

Publications (1)

Publication Number Publication Date
UA115894C2 true UA115894C2 (uk) 2018-01-10

Family

ID=48613829

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201508442A UA115894C2 (uk) 2013-02-28 2014-02-24 Місцева антимікробна дерматологічна композиція

Country Status (23)

Country Link
US (1) US20150343014A1 (uk)
EP (2) EP3287171A1 (uk)
JP (1) JP6440637B2 (uk)
KR (1) KR102193453B1 (uk)
AR (1) AR094976A1 (uk)
BR (1) BR112015020405B1 (uk)
CA (1) CA2897518C (uk)
CY (1) CY1119431T1 (uk)
DK (1) DK2961481T3 (uk)
ES (1) ES2641492T3 (uk)
FR (1) FR3002452B1 (uk)
HR (1) HRP20171446T1 (uk)
HU (1) HUE034470T2 (uk)
LT (1) LT2961481T (uk)
MA (1) MA38344B1 (uk)
MX (1) MX352060B (uk)
PL (1) PL2961481T3 (uk)
PT (1) PT2961481T (uk)
RU (1) RU2668827C2 (uk)
SI (1) SI2961481T1 (uk)
TN (1) TN2015000282A1 (uk)
UA (1) UA115894C2 (uk)
WO (1) WO2014131974A1 (uk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2908345T3 (es) 2013-11-03 2022-04-28 Univ California Líquidos iónicos para la administración transdérmica de medicamentos
WO2017098474A1 (en) * 2015-12-09 2017-06-15 Universidade Do Minho Antimicrobial peptide-loaded hyaluronic acid-based formulations, method of production and uses thereof
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
WO2018044920A1 (en) * 2016-08-29 2018-03-08 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
JP7475018B2 (ja) * 2017-07-25 2024-04-26 ピアス株式会社 皮膚外用組成物
FR3132633B1 (fr) * 2022-02-14 2024-04-12 Thea Lab Composition topique pour son utilisation dans le traitement des blépharites.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600483B2 (en) 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
SE9400036D0 (sv) 1994-01-10 1994-01-10 Pharmacia Ab Low modecular weight hyaluronic acid
CA2205771C (en) * 1997-05-22 2002-05-14 Hyal Pharmaceutical Corporation Improved delivery of disease modifiers
US6809181B2 (en) 2000-06-01 2004-10-26 University Of Iowa Research Foundation Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
SI20877A (sl) * 2001-03-21 2002-10-31 Kemijski inštitut Lipopeptidi, njihova priprava in njihova uporaba za inaktivacijo gram-negativnih bakterij, gram-pozitivnih bakterij in za nevtralizacijo endotoksinov
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
CA2457885A1 (en) * 2001-08-24 2003-03-06 Micrologix Biotech Inc. Antimicrobial and anti-inflammatory peptides
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
SI1654387T1 (sl) * 2003-08-15 2009-10-31 Univ South Florida Materiali in postopki za ujetje patogenov in odstranitev avrintrikarboksilne kisline iz vzorca
US20050118678A1 (en) * 2003-10-17 2005-06-02 Regents Of The University Of Minnesota Modified polypeptides with therapeutic activity and methods of use
CN101155825B (zh) * 2005-02-09 2014-11-26 赫里克斯生物医疗公司 抗微生物六肽
CA2610791C (en) * 2005-06-08 2015-12-01 Cangene Corporation Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
FR2894827B1 (fr) 2005-12-21 2010-10-29 Galderma Res & Dev Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090258045A1 (en) * 2008-03-18 2009-10-15 Massachusetts Institute Of Technology Structures including antimicrobial peptides
JP5646507B2 (ja) * 2009-01-13 2014-12-24 ペルガムム・エイビーＰｅｒｇａｍｕｍ ＡＢ 創傷、傷跡、および手術後の癒着形成を治療するためのヒアルロン酸含有組成物
WO2010109284A1 (en) * 2009-03-27 2010-09-30 University Of Manitoba Antimicrobial cationic lipo-beta-peptides
FR2954945B1 (fr) 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US9629856B2 (en) * 2010-03-03 2017-04-25 Anteis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
CN102552889A (zh) * 2010-12-27 2012-07-11 上海高科联合生物技术研发有限公司 一种生物杀菌滴眼液制剂
RU2460532C1 (ru) * 2011-04-28 2012-09-10 Учреждение Российской академии наук Институт энергетических проблем химической физики РАН Препарат, ускоряющий ранозаживление
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique

Also Published As

Publication number Publication date
AR094976A1 (es) 2015-09-09
MA38344B1 (fr) 2018-11-30
MX352060B (es) 2017-11-08
KR102193453B1 (ko) 2020-12-21
FR3002452B1 (fr) 2016-02-12
LT2961481T (lt) 2017-10-25
EP2961481B1 (fr) 2017-06-28
RU2015140996A (ru) 2017-04-06
HRP20171446T1 (hr) 2017-12-29
CA2897518C (fr) 2021-02-16
SI2961481T1 (en) 2018-01-31
BR112015020405B1 (pt) 2020-07-07
JP6440637B2 (ja) 2018-12-19
CA2897518A1 (fr) 2014-09-04
RU2015140996A3 (uk) 2018-03-12
MX2015010606A (es) 2016-04-21
EP3287171A1 (fr) 2018-02-28
BR112015020405A2 (pt) 2017-07-18
WO2014131974A1 (fr) 2014-09-04
DK2961481T3 (en) 2017-10-09
FR3002452A1 (fr) 2014-08-29
JP2016510017A (ja) 2016-04-04
CY1119431T1 (el) 2018-03-07
US20150343014A1 (en) 2015-12-03
MA38344A1 (fr) 2018-03-30
PL2961481T3 (pl) 2018-01-31
KR20150134325A (ko) 2015-12-01
PT2961481T (pt) 2017-08-18
EP2961481A1 (fr) 2016-01-06
RU2668827C2 (ru) 2018-10-02
HUE034470T2 (en) 2018-02-28
ES2641492T3 (es) 2017-11-10
TN2015000282A1 (fr) 2016-10-03

Similar Documents

Publication Publication Date Title
TN2015000282A1 (fr) Composition dermatologique antimicrobienne topique
HRP20200431T1 (hr) Hidrogel na bazi polimera
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
BR112015027699A2 (pt) Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico
BR112015016002A2 (pt) compostos, composições farmacêuticas, complexos químicos e respectivos usos e método para tratar ou prevenir infecção bacteriana
MX2015010190A (es) Metodos de tratamiento topico para infecciones microbianas.
BR112015027536A8 (pt) composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente.
MX2017015670A (es) Composicion terapeutica.
WO2015038533A3 (en) Sodium channel modulators for the treatment of pain and diabetes
BR112014026058A2 (pt) composições para tratamento tópico de infecções microbianas
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
BR112015017519A2 (pt) compostos e métodos para o tratamento de infecções bacterianas
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
BR112013018365A2 (pt) "peptídeos derivados da lactoferrina humana, uso dos mesmos e composição farmacêutica"
FR2978665B1 (fr) Composition antiseptique
WO2012149608A8 (en) Prenylated hydroxystilbenes
GB201206486D0 (en) Vesicular formulations and uses thereof
EA201401031A1 (ru) Полутвёрдая композиция для местного применения, которая содержит пирфенидон и модифицированный диаллилдисульфид оксид (m-ddo) для удаления или предупреждения угрей
MX2013010308A (es) 2,4-pirimidindiaminas sustituidas para uso en lupus discoide.
UA113151C2 (xx) Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу
BR112016029761A8 (pt) composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TH181272A (th) องค์ประกอบทางผิวหนังวิทยาต้านจุลชีพแบบทา
MX357829B (es) Uso de un hidrolizado de caseína como agente antiherpético.